Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Publication year range
1.
Gan To Kagaku Ryoho ; 35(2): 339-41, 2008 Feb.
Article in Japanese | MEDLINE | ID: mdl-18281779

ABSTRACT

5-FU is among the drugs most frequently used in the treatment of gastrointestinal malignancies. Also, it has been reported to reveal severe side effects in the case of a dihydropyrimidine dehydrogenase (DPD) deficiency. A 75-year-old man showed severe nausea and vomiting after administration of UFT/Uzel as adjuvant chemotherapy. Because of severe thrombocytopenia and grade 4 neutropenia, platelet transfusion and G-CSF administration were performed. With time, the leukocyte, neutrophil and platelet count recovered to normal level. We strongly suspected a DPD deficiency from the result of urinary pyrimidine analysis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Dihydropyrimidine Dehydrogenase Deficiency , Dihydrouracil Dehydrogenase (NAD+)/deficiency , Dihydrouracil Dehydrogenase (NAD+)/metabolism , Dihydrouracil Dehydrogenase (NADP)/metabolism , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Chemotherapy, Adjuvant , Humans , Male , Rectal Neoplasms/drug therapy , Rectal Neoplasms/surgery , Tegafur/administration & dosage , Tegafur/adverse effects , Tegafur/therapeutic use , Uracil/administration & dosage , Uracil/adverse effects , Uracil/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...